Hikma Lines Up US Hybrid Injectable

Deal With Arecor For Undisclosed Drug

 
• By Aidan Fry
  
Vaccine_Vial
Hikma is working with Arecor to develop a ready-to-use injectable for the US market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business